Fortis Healthcare Ltd
NSE:FORTIS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
581.2
1 097.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Fortis Healthcare Ltd
Fortis Healthcare Ltd. emerged as a key player in India's healthcare sector, weaving its story through a series of strategic acquisitions and adept management of a dynamic and challenging industry. Founded in 2001, the company quickly expanded its footprint across India, addressing the growing demand for quality healthcare services in a country where infrastructure and access were traditionally limited. Fortis operates a network of hospitals and diagnostic centers, catering to a wide array of specialties, including cardiology, orthopedics, neuroscience, and oncology. Its robust infrastructure and focus on patient-centered care set it apart, enabling it to offer a diversified portfolio of healthcare services that span routine wellness treatments to complex surgeries.
The business model Fortis Healthcare champions is centered on generating revenue from a combination of inpatient and outpatient services. By leveraging its network of multispecialty hospitals, the company taps into both urban and semi-urban markets, thus maximizing its reach and customer base. Alongside its hospital operations, Fortis profits from specialized diagnostic services, pharmacy sales, and wellness programs, creating multiple streams of revenue. Its ability to attract renowned medical professionals and incorporate cutting-edge technology ensures a steady flow of patients seeking high-quality care. This focus on operational excellence and strategic market positioning allows Fortis Healthcare to navigate and sustain growth in the competitive landscape of Indian healthcare.
Fortis Healthcare Ltd. emerged as a key player in India's healthcare sector, weaving its story through a series of strategic acquisitions and adept management of a dynamic and challenging industry. Founded in 2001, the company quickly expanded its footprint across India, addressing the growing demand for quality healthcare services in a country where infrastructure and access were traditionally limited. Fortis operates a network of hospitals and diagnostic centers, catering to a wide array of specialties, including cardiology, orthopedics, neuroscience, and oncology. Its robust infrastructure and focus on patient-centered care set it apart, enabling it to offer a diversified portfolio of healthcare services that span routine wellness treatments to complex surgeries.
The business model Fortis Healthcare champions is centered on generating revenue from a combination of inpatient and outpatient services. By leveraging its network of multispecialty hospitals, the company taps into both urban and semi-urban markets, thus maximizing its reach and customer base. Alongside its hospital operations, Fortis profits from specialized diagnostic services, pharmacy sales, and wellness programs, creating multiple streams of revenue. Its ability to attract renowned medical professionals and incorporate cutting-edge technology ensures a steady flow of patients seeking high-quality care. This focus on operational excellence and strategic market positioning allows Fortis Healthcare to navigate and sustain growth in the competitive landscape of Indian healthcare.
Revenue Growth: Fortis Healthcare reported consolidated Q2 revenue of INR 2,331 crores, up 17.3% year-on-year, with strong performance across both hospital and diagnostics segments.
Margin Expansion: Consolidated operating EBITDA rose 28% to INR 556 crores, with margins improving to 23.9% from 21.9% last year. Hospital margins also expanded by 150 basis points.
Diagnostics Momentum: Agilus Diagnostics’ revenue grew 7.3% year-on-year and margins improved significantly to 26.1% from 21.5%.
Bed Additions: The company added approximately 550 operational beds in the first half, maintaining its full-year target of 400-500 beds.
Patient Metrics: Hospital occupancy improved to 71%, and ARPOB increased by 5.8%, driven by a better specialty mix and higher share of complex procedures.
International Business: Revenue from medical travel increased 26% year-on-year, now contributing 8.1% to overall hospital revenues.
Guidance & Outlook: Management expects continued growth and further margin improvement, with strong cash flow supporting ongoing expansion.
Legal & Structural Updates: Legal expenses are expected to reduce by about half following recent resolutions, and the company is simplifying its structure for greater efficiency.
